DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
|
DGAP-News: MorphoSys AG
/ Key word(s): Agreement
MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 14.06.2022 / 22:01 The issuer is solely responsible for the content of this announcement. |